|
Moringa in Diabetes |
|
Therapy for COVID-19-Phase I-II |
|
14F7 in chronic B-cell lymphoproliferative syndrome |
|
14F7 MAb marked with Tc99 Phase II in breast tumors. |
|
188Re-marked Ior C5 MAb in persistent or relapsing ovary epithelial cancer, phase I. |
|
1B8 vs MabThera® in patients with Diffuse large B-cell lymphoma |
|
1E10 anti-idiotype vaccine, metastatic breast cancer, phase II |
|
1E10 anti-idiotype vaccine, metastatic colon, phase II. |
|
99mtc-marked 14f7 MAb in colon/rectum tumor, Phase II |
|
99mTc-marked 14F7 MaB in metastatic breast, phase II |
|
A phase I/II study to evaluate the Salmonella Typhi Vi polysaccharide vaccine – vax-TyVi – in children and teenagers. |
|
A phase II study of the Cuban adult formulation tetanus and diphtheria vaccine. |
|
A phase II study of the Cuban vaccine against tetanus and diphtheria VA-DIFTET. |
|
A Study of the Efficacy and Safety of Atezolizumab Plus Chemotherapy for Patients With Early Relapsing Recurrent Triple-Negative Breast Cancer. |
|
A Study to Describe the Diagnosis, Anti-Cancer Treatment and Clinical Outcome in Patients With Newly Diagnosed Breast Cancer in Latin America |
|
A Study to Evaluate Patient Preference and Satisfaction of Subcutaneous Administration of the Fixed-Dose Combination of Pertuzumab and Trastuzumab in Participants With HER2-Positive Early Breast Cancer |
|
ABDALA Clinical Study |
|
ABDALA Clinical Study - Phase III |
|
ABDALA-Intervention |
|
Abexol (suspension) versus Abexol (tablets) in patients with gastrointestinal symptoms |
